title: [Clinical polymorphism of neuroborreliosis at a late stage of the disease].
authors.forename: S O
authors.initials: SO
authors.lastname: Vel'gin
authors.forename: I I
authors.initials: II
authors.lastname: Protas
authors.forename: V V
authors.initials: VV
authors.lastname: Ponomarev
authors.forename: S A
authors.initials: SA
authors.lastname: Drakina
authors.forename: V V
authors.initials: VV
authors.lastname: Shcherba
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D025065:Borrelia burgdorferi / Q000276:immunology; D002908:Chronic Disease; D018450:Disease Progression; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D020852:Lyme Neuroborreliosis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial